Representative before the EPO

Company dna lds lazewski depo and partners
no operation time available
1 office
active in Legal Services

Marek Lazewski has worked on the following 4 EPO patent applications which have been published in the last five years:

EP13003327

Method for conducting a biomass torrefaction process, installation for conducting biomass process, torrified biomass and a method for puryfying flue gases from torrefaction process

IPC classification:
C10L 9/08
Agent:
Marek Lazewski, LDS Lazewski Depo & Partners
Status:
EXAMINATION IN PROGRESS
EP14001527

Animal model for Parkes-Weber syndrome

IPC classification:
A01K 67/027, A61K 36/77
Applicant:
Pharmaceutical Research Institute (Instytut Farmaceutyczny)
Applicant:
Warsaw Medical University (Warszawski Uniwersytet Medyczny)
Agent:
Marek Lazewski, LDS Lazewski Depo & Partners
Status:
PATENT GRANTED
EP14799527

7-AMINOCEPHALOSPORANIC ACID DERIVATIVE AS INHIBITOR OF IL-15 AND IL-2 ACTIVITY

IPC classification:
A61K 31/546, A61P 17/06, A61P 19/02, A61P 37/06
Applicant:
Warsaw Medical University (Warszawski Uniwersytet Medyczny)
Agent:
Marek Lazewski, LDS Lazewski Depo & Partners
Status:
EXAMINATION REQUESTED
EP15460037

ANTIPSORIATIC EMULSION COMPOSITION COMPRISING CEFAZOLIN

IPC classification:
A61K 9/107, A61K 9/113, A61K 31/546, A61K 47/02, A61K 47/06, A61K 47/08, A61K 47/10, A61K 47/18
Applicant:
Pharmaceutical Research Institute (Instytut Farmaceutyczny)
Applicant:
Warsaw Medical University (Warszawski Uniwersytet Medyczny)
Agent:
Marek Lazewski, LDS Lazewski Depo & Partners
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature